Fidelity Investments
BIAF icon

Fidelity Investments’s bioAffinity Technologies BIAF Stock Holding History

Fidelity Investments’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-26
Closed -$77 – 5437
2025
Q3 		$77 Buy
+26
New +$207 ﹤0.01% 5219

Other funds holding BIAF

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments's BIAF Position: Q4 2025 in Review

Fidelity Investments sold out of bioAffinity Technologies (BIAF) in Q4 2025, closing a stake of 26 shares — an estimated $77 sold.

Fidelity Investments first reported a position in BIAF in Q3 2025 and held it in 1 quarter. The position peaked at $77 in Q3 2025. 9 funds tracked by Wall St. Rank hold BIAF as of Q4 2025.

  • Fidelity Investments reported no remaining bioAffinity Technologies position as of Q4 2025 after selling out during the quarter.
  • Fidelity Investments sold 26 bioAffinity Technologies shares in Q4 2025, an estimated $77.
  • Fidelity Investments first reported a position in bioAffinity Technologies in Q3 2025 and held it in 1 quarter.
  • Fidelity Investments's bioAffinity Technologies position peaked at $77 in Q3 2025.
  • 9 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q4 2025.

Based on Fidelity Investments's 13F filing for Q4 2025, filed 17 Feb 2026.